Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
82°
Site search
Search
Menu
Subscribe
Home
News
Local News
Sports
Obituaries
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Explore the Sheyenne
Archives
Best of 2024
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
AbbVie
(NY:
ABBV
)
190.07
+5.47 (+2.96%)
Official Closing Price
Updated: 7:00 PM EDT, May 12, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about AbbVie
< Previous
1
2
3
4
5
6
7
8
9
...
79
80
Next >
AbbVie's Pipeline May Be A 2026 Story, But Analyst Likes The Setup Now
April 22, 2025
Cantor Fitzgerald starts AbbVie with an Overweight rating and $210 target, citing strong drug growth, low risk, and no major patent concerns.
Via
Benzinga
Topics
Intellectual Property
Exposures
Intellectual Property
Spotlight on AbbVie: Analyzing the Surge in Options Activity
April 22, 2025
Via
Benzinga
This StoneCo Analyst Turns Bullish; Here Are Top 5 Upgrades For Tuesday
April 22, 2025
Via
Benzinga
This American Water Works Analyst Begins Coverage On A Bearish Note; Here Are Top 5 Initiations For Tuesday
April 22, 2025
Via
Benzinga
Is the Market Bullish or Bearish on AbbVie?
April 21, 2025
Via
Benzinga
AbbVie Options Trading: A Deep Dive into Market Sentiment
April 15, 2025
Via
Benzinga
AbbVie Unusual Options Activity
April 11, 2025
Via
Benzinga
Is AbbVie Stock a Buy?
April 20, 2025
The pharmaceutical giant has been a roller coaster over the past several months.
Via
The Motley Fool
Topics
Government
Intellectual Property
World Trade
Exposures
Intellectual Property
Political
Tariff
A Congress Member Sold Up To $120K In AbbVie Stock: Here's What You Need To Know
April 18, 2025
Via
Benzinga
$100 Invested In This Stock 5 Years Ago Would Be Worth This Much Today
April 18, 2025
Via
Benzinga
Trump's New Order Targets Drug Pricing Transparency And Medicare Cost Reduction
April 16, 2025
Trump orders multi-part executive order to lower drug prices, reduce Medicare costs. Includes guidance on Medicare drug prices, aligning payments with hospital acquisition costs, and investigating...
Via
Benzinga
Topics
Government
Exposures
Political
Unpacking Q4 Earnings: AbbVie (NYSE:ABBV) In The Context Of Other Therapeutics Stocks
April 16, 2025
The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take a look at how therapeutics stocks fared in Q4, starting with AbbVie...
Via
StockStory
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
34-Year-Old Making $3,400 a Month in Dividends Shares His Top 7 Stocks — 'Be Lucky and Save Relentlessly'
April 14, 2025
Via
Benzinga
After The Tariff Flush, A Fresh Look At AbbVie Pharma
April 14, 2025
If ABBV has truly made a bottom, we should see it clear and close over 182.
Via
Talk Markets
Topics
Stocks / Equities
Meta, TJX, Taiwan Semiconductor Manufacturing And A Health Care Stock: CNBC's 'Final Trades'
April 14, 2025
Via
Benzinga
Omeros' New Leukemia Drug Team Ignites Hope For Cancer Fight
April 11, 2025
Omeros forms oncology committee to guide development of its AML therapy, which showed strong efficacy and safety in preclinical studies targeting leukemia cells.
Via
Benzinga
Eli Lilly, AbbVie, Bristol Myers, Regeneron, And Other Pharma Companies Slide As Donald Trump Confirms Tariffs On Pharma Companies
April 11, 2025
Even as Donald Trump paused the reciprocal tariffs for 90 days, he later confirmed that pharmaceutical companies would face tariffs.
Via
Benzinga
Topics
Government
World Trade
Exposures
Political
Tariff
S&P, Dow Jones Pharma Names Rattled — Again — On Trump's Tariffs Whiplash
April 10, 2025
Here's why the 90-day tariffs delay doesn't help pharmaceutical companies.
Via
Investor's Business Daily
Topics
Government
Stocks
World Trade
Exposures
Political
Tariff
US Equities
3 Biopharmaceutical Stocks Bucking the Sell-Off
April 10, 2025
Three biopharma companies may appeal to investors looking for firms that have not been rocked by tariff-inspired turbulence.
Via
MarketBeat
Topics
World Trade
Exposures
Product Safety
Tariff
The Last Time the Stock Market Started a Year This Badly Was 2022. Is Another Crash Coming?
April 10, 2025
Via
The Motley Fool
Topics
Economy
Government
World Trade
Exposures
Economy
Interest Rates
Political
What's going on in today's session: S&P500 movers
April 09, 2025
Stay updated with the movement of S&P500 stocks in today's session. Discover which S&P500 stocks are making waves on Wednesday.
Via
Chartmill
These S&P500 stocks are gapping in today's session
April 09, 2025
Stay updated with the S&P500 gap up and gap down stocks on Wednesday. Get a glimpse of the market's movement during today's session.
Via
Chartmill
Tech Stocks Rebound As US Treasuries Tumble: What's Driving Markets Wednesday?
April 09, 2025
Wall Street saw a tentative tech rebound early Wednesday, as investors begin to shrug off escalating U.S.-China trade tensions following a steep market selloff.
Via
Benzinga
Topics
World Trade
Exposures
Tariff
Stay updated with the S&P500 stocks that are on the move in today's pre-market session.
April 09, 2025
The US market session of Wednesday has yet to be opened, let's have a look at the top S&P500 gainers and losers in the pre-market session today.
Via
Chartmill
Dow Jones, S&P 500 Pharma Names Slammed As New Trump Tariffs Target Drug Imports
April 09, 2025
Big pharmaceutical names plowed lower Wednesday after Trump on Tuesday said that tariffs would take aim at drug imports.
Via
Investor's Business Daily
Topics
Government
Stocks
World Trade
Exposures
Political
Tariff
US Equities
Elliott Wave Technical Analysis: AbbVie Inc. - Wednesday, April 9
April 09, 2025
ABBV is currently showing a pronounced move down in both daily and 1-hour charts, suggesting a deeper ZigZag correction in play.
Via
Talk Markets
Topics
Stocks / Equities
2 Top Dividend Stocks That Could Set You Up for Life
April 09, 2025
Via
The Motley Fool
Topics
Government
Initial Public Offering
Intellectual Property
Exposures
Intellectual Property
Political
Securities Market
Dr. Oz Officially Confirmed as Head of the Centers for Medicare and Medicaid Services. Here's What Retirees Need to Know So Far.
April 09, 2025
Via
The Motley Fool
Topics
Government
Exposures
Political
3 Dividend Stocks to Buy and Hold for the Next Decade
April 06, 2025
Via
The Motley Fool
Topics
Economy
Intellectual Property
Exposures
Economy
Intellectual Property
2 Dividend Stocks to Buy Hand Over Fist in April
April 05, 2025
Via
The Motley Fool
< Previous
1
2
3
4
5
6
7
8
9
...
79
80
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.